Dr. Ludwin Monz, born in 1963, has been President and CEO of Carl Zeiss Meditec AG since March 2010. Additionally, he has been appointed as the fourth Member of the Executive Board of Carl Zeiss AG effective 1 January 2014.
From 2008 to 2010, Monz headed the Ophthalmic Systems strategic business unit. The unit, which is the market leader in its segments with a broad spectrum of diagnostic and therapy products for ophthalmology, was successfully focused on innovations and realigned by Monz during these two years.
Previously, Monz headed the business unit now known as Microsurgery for over six years. Great challenges were involved in rejuvenating the product portfolio, in improving the company's competitiveness by adopting a clear innovation orientation, and in facilitating growth in a difficult market environment. Besides developing suitable innovation and market strategies, especially in the field of software, Monz also paid particular attention to establishing lean and efficient corporate processes. His commitment helped turn the division into a highly profitable growth sector within the company. Under his management, a number of products were launched which now serve as benchmarks for the industry.
After obtaining his PhD in Physics, Monz spent a year as Invited Visiting Scientist at the National Institute of Standards and Technology in Gaithersburg, USA, before joining ZEISS as a scientist in 1994. He quickly advanced within the ZEISS organization, starting as Head of Geodesic Systems Product Development, before being made general manager for this division which he led in a joint-venture with a Swedish-American company. After obtaining an MBA from Henley Management College in the UK he then joined Carl Zeiss Meditec in 2000 where he was initially responsible for the development of surgical microscopes for microsurgery.
Monz's enthusiasm for science and technology combined with his interest in medical applications pays dividends in his work. He has a passion for outdoor pursuits and is a photography enthusiast.
Dr. Christian Müller, born in 1967, has been a Member of the Management Board at Carl Zeiss Meditec AG since December 2009, where he is responsible for Finance and Controlling, Investor Relations, and Legal and Taxes.
Furthermore, he is responsible for the Surgical Ophthalmology strategic business unit which has developed into a strong ZEISS unit under his successful operational leadership.
After studying business administration in Frankfurt, and later earning his doctorate, he joined the C&L Deutsche Revision auditing company in 1992 where he successfully oversaw the audits of the annual financial statements of numerous companies. He joined VIAG AG in 1997 where he was in charge of numerous auditing and risk management projects, and successfully influenced the continued development of the company’s control system. He was also involved with various M&A projects during this time. In 1999, he transferred to the chemical wing of the company – Degussa AG – where, in his role as head of finance, he was partly responsible for structuring its expansion
Müller joined the ZEISS Group in 2002 as Vice President of Corporate Auditing and Risk Management. He quickly succeeded in implementing a very high quality, systematic risk management system that is still used throughout the Group. In this position, Müller successfully managed a series of projects focused on improving the effectiveness and efficiency of processes and systems. Thereafter, he was increasingly involved with M&A projects. In 2006, he transferred to Medical Systems where he was in charge of the newly created Surgical Ophthalmology strategic business unit with sites in Germany, France and Scotland. Since then, he has successfully, actively and emphatically driven the expansion of the new strategic business unit and realized the integration of IOLTech SA and Acri.Tec AG.
He is married and has two children.